VP of Research and Special Initiatives, Google
Medical College of Wisconsin director of research commercialization
Senior health advisor for Esri
Professor, Michigan State University
Software Engineer at Skelmir
Senior health advisor for Esri
CEO and Co-Founder, Tamr
CEO and co-founder of BoostSuite
The partial government shutdown, now the longest in U.S. history, began to take a bite out of biotech this week, served with a hot side dish of confusion.
On Tuesday, Aimmune Therapeutics (NASDAQ: AIMT) said the shutdown would delay the... Read more »
Fort Worth, TX—Data analytics and visual search technologies are increasingly being used by law enforcement agencies, growth that has captured the attention of tech giant Motorola.
The Chicago-based tech company, which has long sold narrow-band radios to law enforcement, has... Read more »
Billions of dollars have already flowed to the purveyors of shared workspaces, and the investment spigot isn’t turning off yet.
CommonGrounds Workspace, a San Diego, CA-based company that operates flexible office spaces in California and Colorado today, announced Wednesday that it... Read more »
When Propeller Health’s founders initially tried to raise funding for their new healthcare technology venture, many of the investors they spoke with were hesitant to take the risk.
It was the early part of this decade, and Propeller was navigating the... Read more »
Cancer immunotherapy is, in a word, tantalizing. It might save the life of someone at death’s door and keep the cancer at bay for years. Or it might not work at all. There’s no telling what a patient will experience.
“There’s... Read more »
Many of our devices, from wearables to medical instruments to drones, can capture reams of images. Using algorithms to analyze those images on the devices, in turn, generally takes loads of computing power and energy—sometimes more than is feasible.
AlwaysAI says... Read more »
As Xconomy’s editors looked back at the year just passed, we asked technology leaders to comment on the trends they’d observed in 2018, and the developments they expected in 2019. Some leaders responded with their views on the business impact of... Read more »
Teradata on Monday announced that Oliver Ratzesberger, its chief operating officer, has been tapped as president and CEO Victor Lund’s successor.
The company, which last year relocated its headquarters from Dayton, OH, to San Diego, is in the midst... Read more »
The massive life sciences meeting now known as the J.P. Morgan Healthcare Conference started out as a clubby get-together hosted by investment bank Hambrecht & Quist.
Back in the days of H&Q, bankers and entrepreneurs flocked to San Francisco to get... Read more »
[Updated, 1/18/19, 1:10 pm CT] Austin—The grocery store shelf has yet to be plugged into the increasingly digital food supply chain. Instead, inventory is typically tallied by employees by hand in a slow and laborious process.
“It’s one... Read more »
The partial government shutdown may have diminished staffing at the SEC, but it hasn’t dimmed the hopes of biotech firms hoping to go public. On Friday, Kaleido Biosciences and Cirius Therapeutics both filed paperwork for their respective initial public offerings with... Read more »
The changing of the guard transforming retail is accelerating.
Sears, the nation’s first “everything store,” is teetering toward bankruptcy after years of stagnation as industry leaders prepare to gather in New York at the National Retail Federation’s annual conference. Yet, new... Read more »
As federal agency employees miss their first paychecks today due to the partial government shutdown that began Dec. 22, federal contractors and their workers—including technology professionals—face a loss of income that they may never recover.
Big technology companies such as Oracle... Read more »
Diabetes drugs are Eli Lilly’s bread and butter, but the pharmaceutical giant hasn’t lost its appetite for cancer drugs. It grabbed hold of a few more this week by betting $8 billion on Loxo Oncology.
Loxo (NASDAQ: LOXO) has made... Read more »
[Editor’s note: Ben Fidler and Sarah de Crescenzo coauthored this report.] It is here, and then it is gone. But by the time everyone staggers to the airport or back home to sleep in their own beds, the annual... Read more »
The partial government shutdown could soon become the longest shutdown in history, and biotech firms that have submitted regulatory filings are facing greater uncertainty about their future plans. More than 40 percent of FDA workers and thousands at the SEC are... Read more »
The market caps of some of the most successful tech titans reach as high as $1 trillion. Yet in 2018, perceptions about these dominant companies often reflected uneasiness and doubt—and for some, so did their stock performance.
Maybe the mood shift... Read more »
[Updated 1/18/19, 3:27 pm. See below.] Venture capital investments rose in 2018 to levels not seen since the heady days of 2000, the last year U.S. startups collectively took in more than $100 billion.
That’s according to PitchBook and... Read more »
Beta Bionics, a startup developing a medical device that monitors and manages blood sugar levels in diabetes patients, has closed $63 million to back late-stage clinical tests of its AI-powered technology.
The cash tops off a Series B round of funding... Read more »
When we have a chance to view it from a distance, the year 2018 may be seen as a period when innovations in a number of technological fields came together to transform not only the future of computing, but also the... Read more »
From the cloud on down to the floors of supermarkets, the rivalry between Microsoft and Amazon spans many sectors in software, gadgets, and increasingly, retail.
The Seattle-area tech giants are battling—both with one another, and other competitors—to further digitize grocery shopping.... Read more »
The flow of biotech news is particularly heavy today, and for good reason. The annual J.P. Morgan Healthcare Conference, one of the biggest gatherings for the biopharmaceutical industry, kicked off today in San Francisco, and many companies, whether they’re speaking at... Read more »
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Professor, Gene Expression Laboratory, Salk Institute
President and CEO, Biocom
Director, UCSD Division of the California Institute for Telecommunications and Information Technology
Founding Director of Calit2
Founder and CEO, Noble Environmental Technologies
Senior Fellow, Kauffman Foundation
Co-founder and Managing Partner, TVC Capital
Founder and CEO, Isis Pharmaceuticals
Former President and CEO, Regulus Therapeutics
Dean, University of San Diego School of Law
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
